JCO After Hours: A Discussion With Abby Rosenberg and Reshma Jagsi
Dr. Shannon Westin, Dr. Abby Rosenberg, and Dr. Reshma Jagsi discuss the timely issue of diversity, equity, and inclusion in the field of oncology. ...
Journal of Clinical Oncology (JCO) Podcast
Share:
Listens: 42
About
The Journal of Clinical Oncology (JCO) serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. Usually presented in conjunction with an original report and an editorial published on www.jco.org, the JCO podcasts enable readers to stay current on the latest research while placing the results into a clinically useful context.
JCO After Hours: A Discussion With Michael Gnant and Kathy Miller
Dr. Shannon Westin, Dr. Michael Gnant, and Dr. Kathy Miller discuss the results of the PALLAS trial.
JCO After Hours: A Discussion With Kirsten Beyer and Jennifer Griggs
Dr. Shannon Westin, Dr. Kirsten Beyer and Dr. Jennifer Griggs discuss how mortgage lending bias and residential segregation intersect with cancer disp...
Is Dose-Adjusted EPOCH-R the Optimal Treatment for Children with Primary Mediastinal B-Cell Lymphoma?
This podcast will discuss data from a phase II trial evaluating the dose-adjusted EOPCH-R chemo-immunotherapy regimen for the treatment of primary med...
Steroid Dose and Taxanes
This podcast discusses the study, steroid dose reduction, practice experience, and guidance changes. TRANSCRIPT [MUSIC PLAYING] ROBIN ZON: This JCO ...
Commentary on GROINSS VII
Improving care in vulvar cancer via the prospective Vulvar GROINSS VII study TRANSCRIPT This JCO Podcast provides observations and commentary on the...
Harnessing the Power of Registries to Understand the Impact of Treatment for Hodgkin Lymphoma on Fertility
Dr. Lindsay Morton of the National Cancer Institute at the National Institutes of Health reflects on research findings by Øvlisen et al that leverage ...
Subspecialty Palliative Care Involvement May Lessen the Need for High-Intensity End-of-Life Care for Adolescents and Young Adults With Cancer
This podcast describes the findings from a population-based retrospective decedent cohort study which suggest that palliative care involvement may be ...
Can the Incorporation of Minimal Residual Disease Detection Enhance Post-CAR T Outcomes in Patients With Large B-Cell Lymphoma?
Minimal residual disease positivity is predictive of disease progression in patients with large B-cell lymphoma treated with anti-CD19 CAR T-cells. ...
Moving Forward With Venetoclax-Based Combinations in Younger Adults With Acute Myeloid Leukemia
Venetoclax in combination with FLAG-IDA chemotherapy shows safety and promising efficacy in both untreated and relapsed/refractory AML in this phase 1...